1. Home
  2. BEDU vs CELU Comparison

BEDU vs CELU Comparison

Compare BEDU & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bright Scholar Education Holdings Limited each  representing four

BEDU

Bright Scholar Education Holdings Limited each representing four

N/A

Current Price

$2.19

Market Cap

65.0M

Sector

Real Estate

ML Signal

N/A

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.81

Market Cap

56.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEDU
CELU
Founded
1994
2016
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.0M
56.7M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
BEDU
CELU
Price
$2.19
$1.81
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
5.5K
62.1K
Earning Date
01-23-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$224,321,752.00
$40,578,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.35
$1.00
52 Week High
$2.28
$4.35

Technical Indicators

Market Signals
Indicator
BEDU
CELU
Relative Strength Index (RSI) 56.64 44.20
Support Level $2.18 $1.62
Resistance Level $2.20 $2.01
Average True Range (ATR) 0.03 0.12
MACD -0.00 0.01
Stochastic Oscillator 35.71 23.81

Price Performance

Historical Comparison
BEDU
CELU

About BEDU Bright Scholar Education Holdings Limited each representing four

Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom and the United States. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: